Skip to main content

Day: March 23, 2021

J.V.B. Financial Group, LLC Hires New Executive Team to Expand Investment Banking Division of Cohen & Company’s Broker Dealer Subsidiary

PHILADELPHIA and NEW YORK , March 23, 2021 (GLOBE NEWSWIRE) — Cohen & Company Inc. (NYSE American: COHN; “Cohen”), a financial services firm specializing in fixed income markets and, more recently, in special purpose acquisition company (“SPAC”) markets, announced that Dan Nash and Jerry Serowik have joined its indirect, wholly-owned subsidiary J.V.B. Financial Group, LLC (“JVB”). Cohen operates a global network of more than 85 professionals in four principal offices throughout the U.S. and Europe focused on asset management, principal investing, and capital markets services. JVB specializes in securities financing and the sales and trading of fixed income securities. Nash and Serowik will lead the expansion of JVB’s Investment Banking division and work closely with team members at Cohen to create a leading diversified financial...

Continue reading

Rackspace Technology Announces New Solve Strategy Series Webinar: Predicting Your Customer Needs with Modern Data

SAN ANTONIO, March 23, 2021 (GLOBE NEWSWIRE) — Rackspace Technology™ (NASDAQ: RXT), a leading end-to-end multicloud technology solutions company, will hold the virtual event Predicting Your Customer Needs with Modern Data on April 6that 10:00 am CT as part of the company’s Solve Strategy Series. As new technologies transform customer expectations, leading organizations are thriving by adapting their business models and modernizing their data. Jeremiah Owyang, a disruptive tech and corporate innovation expert and Founder of Kaleido Insights & Catalyst Companies, will deliver the keynote on how modernizing your data is a key step to adopting new technology and leveraging the key technology trends impacting customer behavior. Jeremiah’s game-changing session will cover:The pieces involved in modernization and why modernization...

Continue reading

Copenhagen Capital A/S – Ændring af finanskalender

Datoen for offentliggørelse af Årsrapport 2020 er ændret fra tirsdag, den 23. marts 2021 til mandag, den 29. marts 2021. Finanskalenderen for 2021 ser herefter således ud:             29.03.2021        Årsrapport 2020            27.04.2021        Ordinær generalforsamling            18.05.2021        Periodemeddelelse 1. kvartal 2021            31.08.2021        Delårsrapport 2021            30.11.2021        Periodemeddelelse 3. kvartal 2021 Med venlig hilsen Copenhagen Capital A/SAdministrerende direktør Lars FalsterTelefon: +45 70271060Email: lf@copenhagencapital.dk Vedhæftet filSelskabsmeddelelse – Ændring af finanskalender

Continue reading

Indkaldelse til delvis elektronisk generalforsamling 19. april kl 16:00 hos FastPassCorp

På grund af uvisheden om COVID-19 begrænsninger på antal af mødedeltagere afholdes generalforsamlingen som delvis elektronisk generalforsamling. Selskabet beder alle, der ønsker at deltage, om at anvende muligheden for at deltage via den elektroniske adgang for at mindske risikoen for smittespredning. Dagsordenen indeholder 4 afstemninger: 2), 4), 5) og 6). Da det vil ikke være muligt at stemme via den delvise elektroniske deltagelse, anmoder vi alle om at benytte muligheden for at fremsende brevstemmer eller afgive fuldmagter til selskabets formand eller direktør senest den 16. april kl 12. Se dagsorden i vedlagte PDF Se forslag til nye vedtægter i vedlagte PDF Yderligere oplysningerFastPassCorp A/S, administrerende direktør Finn Jensen, mobil 24 81 12 79, fj@fastpasscorp.com Certified AdviserBaker Tilly Corporate Finance P/S, partner...

Continue reading

LITGRID AB publishes Financial statements and Annual report for the year 2020 in ESEF format

LITGRID AB (company code 302564383, registered office address Viršuliškių skg. 99B, Vilnius) publishes Company’s Financial statements and Annual report for the year ended 31 December 2020 in XHTML in accordance with European Single Electronic Format (ESEF) requirements. Please note, that these documents are not audited for compliance with ESEF requirements and should serve as additional information only. For the reference, Company’s Financial statements, Annual report and the Independent auditor’s report for the year ended 31 December 2020 were published on 16 March 2021: https://cns.omxgroup.com/cdsPublic/viewDisclosure.action?disclosureId=1010026&messageId=1265051 Attached:LITGRID AB Financial statements and Annual report for the year 2020 in ESEF format.  The individual authorized by LITGRID AB to provide additional...

Continue reading

LITGRID AB skelbia 2020 m. Bendrovės finansinių ataskaitų rinkinį ESEF formatu

LITGRID AB skelbia 2020 m. Bendrovės finansinių ataskaitų rinkinį ESEF formatu LITGRID AB (įmonės kodas 302564383, registruotos buveinės adresas Viršuliškių skg. 99B, Vilnius) skelbia Bendrovės finansines ataskaitas ir metinį pranešimą už metus, pasibaigusius 2020 gruodžio 31 d. XHTML formatu pagal Europos vieno elektroninio ataskaitų teikimo (ESEF) reikalavimus. Atkreipiame dėmesį, kad tai yra papildoma informacija ir skelbiami dokumentai nėra audituoti dėl atitikties ESEF reikalavimams. Primename, kad Bendrovės finansinės ataskaitos, metinis pranešimas ir nepriklausomo audito išvada už metus, pasibaigusius 2020 gruodžio 31 d., buvo paskelbti 2021 m. kovo 16 d.: https://cns.omxgroup.com/cdsPublic/viewDisclosure.action?disclosureId=1010026&messageId=1265050 Pridedama:LITGRID AB 2020 m. Finansinių ataskaitos ir metinis pranešimas...

Continue reading

Predictmedix Inc. Announces LOI to Acquire Symp2pass Inc.

TORONTO, March 23, 2021 (GLOBE NEWSWIRE) — Predictmedix Inc. (CSE:PMED) (OTCQB:PMEDF) (“Predictmedix” or the “Company”) is pleased to announce it has entered into a letter of intent (the “LOI”), to acquire Symp2Pass Inc. (“Symp2pass”) (the “Acquisition”). The LOI was executed on February 24, 2021 and currently Predictmedix and Symp2pass are working on the definitive agreement. Symp2Pass is a profitable, revenue generating AI powered IoT product suite of technologies developed by SmartCone Technologies Inc. Symp2Pass had revenues of $2.27 million for the fiscal year ending December 31, 2020 (unaudited) with earnings before taxes of approximately $205,000. Symp2Pass is one of the first end-to-end advanced touchless health and wellness testing solutions that currently provides...

Continue reading

Herborium Moves to the Next Level in Building a Disruptive, Integrated, Natural Medicine Content and Commerce Platform

Houston, Texas, March 23, 2021 (GLOBE NEWSWIRE) — Herborium Group, Inc.  (OTC Pink: HBRM),  a Botanical Therapeutics Company and the provider of unique, all botanical medicinal products (Botanical Therapeutics®) announced today that it is making considerable progress towards its goal of introducing a new, innovative, all natural product to expand Herborium’s product portfolio in 3Q21. In addition, the Company has entered into an advanced planning stage for a unique content product to be launched in 2022. Content is the most sought after value creator in today’s digital commerce. The worldwide revenue generated by content was $208.3 billion in 2019 and is expected to grow to $414.2 billion by 2025. Herborium’s CEO Dr. Agnes Olszewski noted, “Herborium’s new content and innovative Artificial Intelligence platform is being designed...

Continue reading

UPDATE: Galecto Hosting Expert Perspective Panel on the Evolving Treatment Landscape for Idiopathic Pulmonary Fibrosis and Potential for GB0139

BOSTON, March 23, 2021 (GLOBE NEWSWIRE) — Galecto, Inc. (NASDAQ: GLTO), a biotechnology company focused on the development of novel treatments for fibrosis and cancer, today announced it will host an expert perspectives panel on the evolving treatment landscape for idiopathic pulmonary fibrosis (IPF) and the potential for GB0139 on Tuesday, March 30, 2021 at 2pm Eastern Time. The webinar will feature a presentation by Key Opinion Leader (KOL) Toby Maher, MD, University of Southern California, who will discuss the current treatment landscape and unmet medical need in treating patients with IPF, as well as the clinical meaning of the exciting biomarker data on GB0139 recently published in the European Respiratory Journal, which showed marked impact on several IPF biomarkers. GB0139 is Galecto’s inhalable, once-daily treatment for...

Continue reading

Women in Trucking Association Honors 11 Yellow Leaders as “Top Women to Watch in Transportation”

OVERLAND PARK, Kan., March 23, 2021 (GLOBE NEWSWIRE) — Yellow Corporation (NASDAQ: YELL) – The Women in Trucking Association has named 11 women from Yellow to its 2021 “Top Women to Watch in Transportation” list. These leaders represent nearly every function area across the Company, and this is the third time the Association has honored Yellow employees on its “Top Women to Watch in Transportation” list. The editorial staff of WIT’s Redefining the Road magazine selected these individuals for their significant career accomplishments in the past 12 to 18 months as well as their efforts to promote gender diversity.  “It’s always exciting when a third-party recognizes the contributions of our employees, who in this case are among the trucking industry’s top professionals,” said Darren Hawkins, CEO. “The contributions of these women...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.